Contrast-enhanced CT-based radiomics differentiate anterior mediastinum lymphoma from thymoma without myasthenia gravis and calcification

To explore the value of a radiomics model based on enhanced computed tomography (CT) in differentiating anterior mediastinal lymphoma (AML) and thymoma without myasthenia gravis (MG) and calcification. The present study analysed patients who were diagnosed histologically with AML and thymoma in thre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical radiology 2024-04, Vol.79 (4), p.e500-e510
Hauptverfasser: Huang, X., Wang, X., Liu, Y., Wang, Z., Li, S., Kuang, P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e510
container_issue 4
container_start_page e500
container_title Clinical radiology
container_volume 79
creator Huang, X.
Wang, X.
Liu, Y.
Wang, Z.
Li, S.
Kuang, P.
description To explore the value of a radiomics model based on enhanced computed tomography (CT) in differentiating anterior mediastinal lymphoma (AML) and thymoma without myasthenia gravis (MG) and calcification. The present study analysed patients who were diagnosed histologically with AML and thymoma in three independent institutions. All pre-treatment patients underwent enhanced CT. In the training group of patients from institutions 1 (the First Affiliated Hospital of Kunming Medical University) and 3 (the Yunnan Cancer Hospital), two radiologists independently analysed the enhanced CT images and performed manual segmentation of each tumour. Radiomics features were screened using interobserver interclass coefficient (ICC) analysis, feature correlation analysis, and L1 regularisation. The discriminative efficacy of the logistic regression model was evaluated using receiver operating characteristic (ROC) analysis. Validation group of patients from institution 2 (the Second Affiliated Hospital of Zhejiang University School of Medicine) was used to validate the proposed models. A total of 114 patients were enrolled in this study and 1,743 radiomics features were extracted from the enhanced CT images. After feature screening, the remaining 37 robust radiomics features were used to construct the model. In the training group, the AUC of the model was 0.987 (95% confidence interval [CI]: 0.976–0.999), the sensitivity, specificity, and accuracy were 0.912, 0.946, and 0.924, respectively. In the validation group, the AUC of the model was 0.798 (95% CI: 0.683–0.913), the sensitivity, specificity, and accuracy were 0.760, 0.700, and 0.743, respectively. The radiomics model created provided effective information to assist in the selection of clinical strategies, thus reducing unnecessary procedures in patients with AML and guiding direct surgery in patients with thymoma to avoid biopsy. •Multicenter acquisition of lymphoma and thymoma cases.•Explore the effective radiomics features for distinguishing lymphoma from thymoma.•Myasthenia gravis and calcification were firstly proposed as exclusion criteria.
doi_str_mv 10.1016/j.crad.2023.12.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2929056504</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009926024000102</els_id><sourcerecordid>2929056504</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-4569e873449d31b796e94f7d28150d607d1b5a0636b395ca3431c0e9779c98033</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS1ERaeFF2CBvGST4L_8WGKDRi1UqsSmSOwsx74hHsXxYDtF8wh96zqawpLVvVf6zpHuOQi9p6SmhLafDrWJ2taMMF5TVhPavUI7ytumYkz-fI12hBBZSdaSS3SV0mE7BRNv0CXvmWA9ETv0tA9LjjrlCpZJLwYs3j9Ug05lKeYueGcStm4cIcKSnc6A9ZIhuhCxB-uK1C2rx_PJH6fgNR5j8DhPJ78df1yewpqxPxVugsVp_CvqR5eKicVGz8aNzujswvIWXYx6TvDuZV6jH7c3D_tv1f33r3f7L_eV4aTLlWhaCX3HhZCW06GTLUgxdpb1tCG2JZ2lQ6NJy9uBy8ZoLjg1BGTXSSN7wvk1-nj2Pcbwe4WUlXfJwDzrBcKaFJNMkqZtiCgoO6MmhpQijOoYndfxpChRWwXqoLYK1FaBokyVCorow4v_OpSA_kn-Zl6Az2cAypePDqJKxsEWvYtgsrLB_c__GXJhmgE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2929056504</pqid></control><display><type>article</type><title>Contrast-enhanced CT-based radiomics differentiate anterior mediastinum lymphoma from thymoma without myasthenia gravis and calcification</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Huang, X. ; Wang, X. ; Liu, Y. ; Wang, Z. ; Li, S. ; Kuang, P.</creator><creatorcontrib>Huang, X. ; Wang, X. ; Liu, Y. ; Wang, Z. ; Li, S. ; Kuang, P.</creatorcontrib><description>To explore the value of a radiomics model based on enhanced computed tomography (CT) in differentiating anterior mediastinal lymphoma (AML) and thymoma without myasthenia gravis (MG) and calcification. The present study analysed patients who were diagnosed histologically with AML and thymoma in three independent institutions. All pre-treatment patients underwent enhanced CT. In the training group of patients from institutions 1 (the First Affiliated Hospital of Kunming Medical University) and 3 (the Yunnan Cancer Hospital), two radiologists independently analysed the enhanced CT images and performed manual segmentation of each tumour. Radiomics features were screened using interobserver interclass coefficient (ICC) analysis, feature correlation analysis, and L1 regularisation. The discriminative efficacy of the logistic regression model was evaluated using receiver operating characteristic (ROC) analysis. Validation group of patients from institution 2 (the Second Affiliated Hospital of Zhejiang University School of Medicine) was used to validate the proposed models. A total of 114 patients were enrolled in this study and 1,743 radiomics features were extracted from the enhanced CT images. After feature screening, the remaining 37 robust radiomics features were used to construct the model. In the training group, the AUC of the model was 0.987 (95% confidence interval [CI]: 0.976–0.999), the sensitivity, specificity, and accuracy were 0.912, 0.946, and 0.924, respectively. In the validation group, the AUC of the model was 0.798 (95% CI: 0.683–0.913), the sensitivity, specificity, and accuracy were 0.760, 0.700, and 0.743, respectively. The radiomics model created provided effective information to assist in the selection of clinical strategies, thus reducing unnecessary procedures in patients with AML and guiding direct surgery in patients with thymoma to avoid biopsy. •Multicenter acquisition of lymphoma and thymoma cases.•Explore the effective radiomics features for distinguishing lymphoma from thymoma.•Myasthenia gravis and calcification were firstly proposed as exclusion criteria.</description><identifier>ISSN: 0009-9260</identifier><identifier>ISSN: 1365-229X</identifier><identifier>EISSN: 1365-229X</identifier><identifier>DOI: 10.1016/j.crad.2023.12.017</identifier><identifier>PMID: 38242804</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Calcinosis ; China ; Humans ; Leukemia, Myeloid, Acute ; Lymphoma - diagnostic imaging ; Mediastinum ; Myasthenia Gravis - complications ; Myasthenia Gravis - diagnostic imaging ; Radiomics ; Retrospective Studies ; Thymoma - diagnostic imaging ; Thymus Neoplasms - diagnostic imaging</subject><ispartof>Clinical radiology, 2024-04, Vol.79 (4), p.e500-e510</ispartof><rights>2024 The Royal College of Radiologists</rights><rights>Copyright © 2024 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-4569e873449d31b796e94f7d28150d607d1b5a0636b395ca3431c0e9779c98033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.crad.2023.12.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38242804$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, X.</creatorcontrib><creatorcontrib>Wang, X.</creatorcontrib><creatorcontrib>Liu, Y.</creatorcontrib><creatorcontrib>Wang, Z.</creatorcontrib><creatorcontrib>Li, S.</creatorcontrib><creatorcontrib>Kuang, P.</creatorcontrib><title>Contrast-enhanced CT-based radiomics differentiate anterior mediastinum lymphoma from thymoma without myasthenia gravis and calcification</title><title>Clinical radiology</title><addtitle>Clin Radiol</addtitle><description>To explore the value of a radiomics model based on enhanced computed tomography (CT) in differentiating anterior mediastinal lymphoma (AML) and thymoma without myasthenia gravis (MG) and calcification. The present study analysed patients who were diagnosed histologically with AML and thymoma in three independent institutions. All pre-treatment patients underwent enhanced CT. In the training group of patients from institutions 1 (the First Affiliated Hospital of Kunming Medical University) and 3 (the Yunnan Cancer Hospital), two radiologists independently analysed the enhanced CT images and performed manual segmentation of each tumour. Radiomics features were screened using interobserver interclass coefficient (ICC) analysis, feature correlation analysis, and L1 regularisation. The discriminative efficacy of the logistic regression model was evaluated using receiver operating characteristic (ROC) analysis. Validation group of patients from institution 2 (the Second Affiliated Hospital of Zhejiang University School of Medicine) was used to validate the proposed models. A total of 114 patients were enrolled in this study and 1,743 radiomics features were extracted from the enhanced CT images. After feature screening, the remaining 37 robust radiomics features were used to construct the model. In the training group, the AUC of the model was 0.987 (95% confidence interval [CI]: 0.976–0.999), the sensitivity, specificity, and accuracy were 0.912, 0.946, and 0.924, respectively. In the validation group, the AUC of the model was 0.798 (95% CI: 0.683–0.913), the sensitivity, specificity, and accuracy were 0.760, 0.700, and 0.743, respectively. The radiomics model created provided effective information to assist in the selection of clinical strategies, thus reducing unnecessary procedures in patients with AML and guiding direct surgery in patients with thymoma to avoid biopsy. •Multicenter acquisition of lymphoma and thymoma cases.•Explore the effective radiomics features for distinguishing lymphoma from thymoma.•Myasthenia gravis and calcification were firstly proposed as exclusion criteria.</description><subject>Calcinosis</subject><subject>China</subject><subject>Humans</subject><subject>Leukemia, Myeloid, Acute</subject><subject>Lymphoma - diagnostic imaging</subject><subject>Mediastinum</subject><subject>Myasthenia Gravis - complications</subject><subject>Myasthenia Gravis - diagnostic imaging</subject><subject>Radiomics</subject><subject>Retrospective Studies</subject><subject>Thymoma - diagnostic imaging</subject><subject>Thymus Neoplasms - diagnostic imaging</subject><issn>0009-9260</issn><issn>1365-229X</issn><issn>1365-229X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhS1ERaeFF2CBvGST4L_8WGKDRi1UqsSmSOwsx74hHsXxYDtF8wh96zqawpLVvVf6zpHuOQi9p6SmhLafDrWJ2taMMF5TVhPavUI7ytumYkz-fI12hBBZSdaSS3SV0mE7BRNv0CXvmWA9ETv0tA9LjjrlCpZJLwYs3j9Ug05lKeYueGcStm4cIcKSnc6A9ZIhuhCxB-uK1C2rx_PJH6fgNR5j8DhPJ78df1yewpqxPxVugsVp_CvqR5eKicVGz8aNzujswvIWXYx6TvDuZV6jH7c3D_tv1f33r3f7L_eV4aTLlWhaCX3HhZCW06GTLUgxdpb1tCG2JZ2lQ6NJy9uBy8ZoLjg1BGTXSSN7wvk1-nj2Pcbwe4WUlXfJwDzrBcKaFJNMkqZtiCgoO6MmhpQijOoYndfxpChRWwXqoLYK1FaBokyVCorow4v_OpSA_kn-Zl6Az2cAypePDqJKxsEWvYtgsrLB_c__GXJhmgE</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Huang, X.</creator><creator>Wang, X.</creator><creator>Liu, Y.</creator><creator>Wang, Z.</creator><creator>Li, S.</creator><creator>Kuang, P.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202404</creationdate><title>Contrast-enhanced CT-based radiomics differentiate anterior mediastinum lymphoma from thymoma without myasthenia gravis and calcification</title><author>Huang, X. ; Wang, X. ; Liu, Y. ; Wang, Z. ; Li, S. ; Kuang, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-4569e873449d31b796e94f7d28150d607d1b5a0636b395ca3431c0e9779c98033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Calcinosis</topic><topic>China</topic><topic>Humans</topic><topic>Leukemia, Myeloid, Acute</topic><topic>Lymphoma - diagnostic imaging</topic><topic>Mediastinum</topic><topic>Myasthenia Gravis - complications</topic><topic>Myasthenia Gravis - diagnostic imaging</topic><topic>Radiomics</topic><topic>Retrospective Studies</topic><topic>Thymoma - diagnostic imaging</topic><topic>Thymus Neoplasms - diagnostic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, X.</creatorcontrib><creatorcontrib>Wang, X.</creatorcontrib><creatorcontrib>Liu, Y.</creatorcontrib><creatorcontrib>Wang, Z.</creatorcontrib><creatorcontrib>Li, S.</creatorcontrib><creatorcontrib>Kuang, P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, X.</au><au>Wang, X.</au><au>Liu, Y.</au><au>Wang, Z.</au><au>Li, S.</au><au>Kuang, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contrast-enhanced CT-based radiomics differentiate anterior mediastinum lymphoma from thymoma without myasthenia gravis and calcification</atitle><jtitle>Clinical radiology</jtitle><addtitle>Clin Radiol</addtitle><date>2024-04</date><risdate>2024</risdate><volume>79</volume><issue>4</issue><spage>e500</spage><epage>e510</epage><pages>e500-e510</pages><issn>0009-9260</issn><issn>1365-229X</issn><eissn>1365-229X</eissn><abstract>To explore the value of a radiomics model based on enhanced computed tomography (CT) in differentiating anterior mediastinal lymphoma (AML) and thymoma without myasthenia gravis (MG) and calcification. The present study analysed patients who were diagnosed histologically with AML and thymoma in three independent institutions. All pre-treatment patients underwent enhanced CT. In the training group of patients from institutions 1 (the First Affiliated Hospital of Kunming Medical University) and 3 (the Yunnan Cancer Hospital), two radiologists independently analysed the enhanced CT images and performed manual segmentation of each tumour. Radiomics features were screened using interobserver interclass coefficient (ICC) analysis, feature correlation analysis, and L1 regularisation. The discriminative efficacy of the logistic regression model was evaluated using receiver operating characteristic (ROC) analysis. Validation group of patients from institution 2 (the Second Affiliated Hospital of Zhejiang University School of Medicine) was used to validate the proposed models. A total of 114 patients were enrolled in this study and 1,743 radiomics features were extracted from the enhanced CT images. After feature screening, the remaining 37 robust radiomics features were used to construct the model. In the training group, the AUC of the model was 0.987 (95% confidence interval [CI]: 0.976–0.999), the sensitivity, specificity, and accuracy were 0.912, 0.946, and 0.924, respectively. In the validation group, the AUC of the model was 0.798 (95% CI: 0.683–0.913), the sensitivity, specificity, and accuracy were 0.760, 0.700, and 0.743, respectively. The radiomics model created provided effective information to assist in the selection of clinical strategies, thus reducing unnecessary procedures in patients with AML and guiding direct surgery in patients with thymoma to avoid biopsy. •Multicenter acquisition of lymphoma and thymoma cases.•Explore the effective radiomics features for distinguishing lymphoma from thymoma.•Myasthenia gravis and calcification were firstly proposed as exclusion criteria.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>38242804</pmid><doi>10.1016/j.crad.2023.12.017</doi></addata></record>
fulltext fulltext
identifier ISSN: 0009-9260
ispartof Clinical radiology, 2024-04, Vol.79 (4), p.e500-e510
issn 0009-9260
1365-229X
1365-229X
language eng
recordid cdi_proquest_miscellaneous_2929056504
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Calcinosis
China
Humans
Leukemia, Myeloid, Acute
Lymphoma - diagnostic imaging
Mediastinum
Myasthenia Gravis - complications
Myasthenia Gravis - diagnostic imaging
Radiomics
Retrospective Studies
Thymoma - diagnostic imaging
Thymus Neoplasms - diagnostic imaging
title Contrast-enhanced CT-based radiomics differentiate anterior mediastinum lymphoma from thymoma without myasthenia gravis and calcification
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T09%3A28%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contrast-enhanced%20CT-based%20radiomics%20differentiate%20anterior%20mediastinum%20lymphoma%20from%20thymoma%20without%20myasthenia%20gravis%20and%20calcification&rft.jtitle=Clinical%20radiology&rft.au=Huang,%20X.&rft.date=2024-04&rft.volume=79&rft.issue=4&rft.spage=e500&rft.epage=e510&rft.pages=e500-e510&rft.issn=0009-9260&rft.eissn=1365-229X&rft_id=info:doi/10.1016/j.crad.2023.12.017&rft_dat=%3Cproquest_cross%3E2929056504%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2929056504&rft_id=info:pmid/38242804&rft_els_id=S0009926024000102&rfr_iscdi=true